COLM vs REGN · P/E 20, rev $3.37B vs P/E 14, rev $14.34B
Columbia Sportswear Company (COLM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Columbia Sportswear Company (COLM) is a apparel manufacturing company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported COLM revenue for 2024-12-31 was $3.37B. Net income was $223.3M. Revenue was down 3.4% from 2023-12-31 to 2024-12-31. COLM currently screens at market cap $3.27B and trailing P/E 20.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
COLM currently screens at market cap $3.27B and trailing P/E 20.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the COLM and REGN stock pages for the full models.
Not investment advice.